GMO GlobalSign Holdings K.K.
GMO GlobalSign Holdings K.K. (3788.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for GMO GlobalSign Holdings K.K. (3788.T), featuring income statements, balance sheets, and cash flow data.
GMO GlobalSign Holdings K.K. (3788.T) Income Statement & Financial Overview
Explore comprehensive income reports for GMO GlobalSign Holdings K.K. 3788.T, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.91B | $5.09B | $4.50B | $4.85B |
| Cost of Revenue | $1.99B | $2.004B | $1.89B | $1.99B |
| Gross Profit | $2.92B | $3.09B | $2.62B | $2.86B |
| Gross Profit Ratio | $0.60 | $0.61 | $0.58 | $0.59 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.64B | $2.66B | $2.55B | $2.50B |
| Operating Expenses | $2.64B | $2.66B | $2.55B | $2.54B |
| Total Costs & Expenses | $4.62B | $4.66B | $4.43B | $4.52B |
| Interest Income | $12.67M | $0.00 | $0.00 | $9.24M |
| Interest Expense | $6.91M | $0.00 | $0.00 | $5.91M |
| Depreciation & Amortization | $422.55M | $394.50M | $307.75M | $384.01M |
| EBITDA | $713.10M | $826.50M | $377.75M | $705.22M |
| EBITDA Ratio | $0.15 | $0.16 | $0.08 | $0.15 |
| Operating Income | $285.17M | $431.00M | $71.00M | $321.21M |
| Operating Income Ratio | $0.06 | $0.08 | $0.02 | $0.07 |
| Other Income/Expenses (Net) | -$1.53M | $22.00M | -$38.00M | -$11.42M |
| Income Before Tax | $283.64M | $453.00M | $33.00M | $309.79M |
| Income Before Tax Ratio | $0.06 | $0.09 | $0.007 | $0.06 |
| Income Tax Expense | $79.81M | $123.00M | $11.00M | $135.77M |
| Net Income | $202.41M | $326.00M | $21.00M | $172.67M |
| Net Income Ratio | $0.04 | $0.06 | $0.005 | $0.04 |
| EPS | $17.63 | $28.35 | $1.82 | $14.99 |
| Diluted EPS | $17.63 | $28.35 | $1.82 | $14.99 |
| Weighted Avg Shares Outstanding | $11.48M | $11.50M | $11.52M | $11.52M |
| Weighted Avg Shares Outstanding (Diluted) | $11.48M | $11.50M | $11.52M | $11.52M |
Over the last four quarters, GMO GlobalSign Holdings K.K.'s revenue moved from $4.85B in Q2 2024 to $4.91B in Q1 2025. Operating income in Q1 2025 was $285.17M, with a strong operating margin of 6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for GMO GlobalSign Holdings K.K. remained robust at $713.10M, reflecting operational efficiency. Net income dropped to $202.41M, with an EPS of $17.63. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan